Pricing Log in Create free account

Structure Therapeutics Inc. Sponsored ADR (GPCR) vs Taysha Gene Therapies, Inc. (TSHA)

Structure Therapeutics Inc. Sponsored ADR and Taysha Gene Therapies, Inc. are both Biotechnology companies. Structure Therapeutics Inc. Sponsored ADR and Taysha Gene Therapies, Inc. are of similar size ($1.4B and $1.3B). Across the 11 metrics below, Taysha Gene Therapies, Inc. leads on 6 and Structure Therapeutics Inc. Sponsored ADR on 5.

Valuation

Metric GPCR TSHA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 136.10 9.40
P/B 1.09 4.15 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 101.67 9.02
Earnings yield (15.31%) (9.66%) (32.88%)
Free cash flow yield (15.20%) (8.66%) (23.13%)

Profitability

Metric GPCR TSHA Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (20.21%) (47.05%) (51.96%)
Return on assets (19.17%) (37.23%) (46.06%)
Return on invested capital (1,371.78%) 0.00% 0.00%

Growth

Metric GPCR TSHA Biotechnology median
Revenue growth (TTM) — 18.96% 6.76%
EPS growth (last fiscal year) (2.47%) 5.56% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GPCR TSHA Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 20.75 17.76 4.97
Net debt to EBITDA 8.27 2.47 1.01

Dividend

Metric GPCR TSHA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GPCR TSHA Biotechnology median
Market cap 1.36b 1.33b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack